Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065257

President sold 15,000 shares at an average $63.53 ($953,015)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
RUBINSTEIN JULIE President 2020-12-24 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-24 Sale −3,487 $62.15 $216,717 11,513 D
RUBINSTEIN JULIE President 2020-12-24 Sale −7,394 $63.71 $471,072 4,119 D
RUBINSTEIN JULIE President 2020-12-24 Sale −3,741 $64.29 $240,509 378 D
RUBINSTEIN JULIE President 2020-12-24 Sale −378 $65.39 $24,717 0 D
Derivatives
RUBINSTEIN JULIE President 2020-12-24 Option exercise · Stock Option (Right to Buy) −15,000 440,000 D
Open-market sales · 15,000 sh · avg $63.53 · $953,015
Loading xslF345X03/doc4.xml…